Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -263.52x is 244% below its 4-year average of -76.66x, near the low end of its 4-year range (-286.68x–50.09x).
As of the fiscal period ended Monday, March 31, 2025. 96.00% below its 12-month average of -134.44x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2025 (2025-03-31): -263.52x.
INTEREST COVERAGE RATIO
-263.52x
INTEREST COVERAGE RATIO AVG TTM
-134.44x
INTEREST COVERAGE RATIO AVG 3Y
-96.68x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-96.00%
CURRENT VS 3Y AVG
-172.55%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-4033.60%
vs the sector median at left
Alpha Cognition Inc
Market Cap
$138.38M
Interest Coverage Ratio
-263.52x
TTM Avg
-134.44x
3Y Avg
-96.68x
5Y Avg
N/A
Market Cap
$140.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.93M
Interest Coverage Ratio
-2.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$138.03M
Interest Coverage Ratio
N/A
TTM Avg
346.24x
3Y Avg
936.28x
5Y Avg
577.46x
Market Cap
$136.58M
Interest Coverage Ratio
N/A
TTM Avg
2.09x
3Y Avg
2.35x
5Y Avg
2.35x
Market Cap
$135.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$144.06M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $138.38M | -263.52x | -134.44x | -96.68x | N/A |
| Immuneering Corporation (IMRX)vs › | $140.13M | N/A | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $139.93M | -2.75x | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.03M | N/A | 346.24x | 936.28x | 577.46x |
| Organigram Global Inc. (OGI)vs › | $136.58M | N/A | 2.09x | 2.35x | 2.35x |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.82M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $142.60M | -49.05x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $144.06M | -8.06x | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.01M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
Interest Coverage
-263.5x
Debt/Equity
0.00
Current Ratio
9.03
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-03-31 | -263.52x |
| 2024-12-31 | -115.13x |
| 2024-09-30 | -19.07x |
| 2024-06-30 | -66.59x |
| 2024-03-31 | -207.91x |
| 2023-12-31 | 50.09x |
| 2023-09-30 | -286.68x |
| 2023-06-30 | -150.34x |
| 2023-03-31 | -72.76x |
| 2022-12-31 | -78.42x |
| 2022-09-30 | -57.22x |
| 2022-06-30 | -104.99x |
| 2022-03-31 | -74.36x |
| 2021-12-31 | -106.23x |
| 2021-09-30 | -83.30x |
| 2021-06-30 | -63.26x |
| 2021-03-31 | -4.90x |
